Quantigen BioSciences, an affiliate of Versiti Clinical Trials (VCT), is a CLIA/CAP-accredited, ISO 15189-certified, GLP- and GCP-compliant contract research laboratory with expertise in the design and optimization of molecular and protein-based assay workflows. As part of VCT, we and our partners can support any or all critical functions of multi-phase clinical studies, from early-stage R&D, protocol development, lab testing, trial management, and regulatory filings and approvals. Our own lab team’s core areas of expertise include high-throughput qPCR platforms, SNP genotyping, capillary and next-generation sequencing, DNA and RNA purification, mass spec, cell culture, to name just a few. While we have helped our clients in numerous disciplines, Quantigen has particular interest in the areas of oncology, HLA, and infectious disease.